Table 5.

Stages of CKD (At time of KFD) in population that developed a decrease in GFR 25% or more in comparison to baseline (Time of Transplant). Kidney disease was stratified using the system advocated by the American National Kidney Foundation Kidney Disease Outcomes Initiative3: stage 1, eGFR 90.0 ml/min per 1.73 m2; stage 2, eGFR 60.0–89.9 ml/min per 1.73 m2; CKD3a − GFR 45 to 59 mL/min per 1.73 m2, CKD3b − GFR 30 to 44 mL/min per 1.73 m2; stage 4, eGFR 15.0–29.9 ml/min per 1.73 m2; and stage 5, eGFR <15.0

Stage	Baseline (n=2477)	KFD time (n=944)
1	1534 (62%)	29 (3%)
2	853 (34%)	334 (35%)
3A	89 (4%)	297 (31%)
3B	1 (0%)	195 (21%)
4	-	79 (8%)
5	-	10 (1%)